| P2093 | author name string | Hong Yu | |
| | Wei Xu | |
| | Lin Zhu | |
| | Tong Zhu | |
| | Shi-Yuan Liu | |
| | Xiang-Sheng Xiao | |
| | Yi-Nan Chen | |
| | Wei-Hua Dong | |
| P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| | Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer | Q57272687 |
| | Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family | Q69752161 |
| | Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker | Q73791090 |
| | Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer | Q79401715 |
| | Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer | Q80962534 |
| | Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib | Q87553002 |
| | Global cancer statistics | Q22241238 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma | Q24619865 |
| | Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential | Q27676429 |
| | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| | Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 |
| | Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 |
| | Aggregate data meta-analysis with time-to-event outcomes | Q30742997 |
| | The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer | Q33451434 |
| | Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? | Q34143336 |
| | Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9. | Q34432435 |
| | TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis | Q35359610 |
| | Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia | Q35747149 |
| | TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis | Q36108579 |
| | The Complex Interaction of Matrix Metalloproteinases in the Migration of Cancer Cells through Breast Tissue Stroma | Q37700768 |
| | The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis | Q37731543 |
| | Carcinoembryonic antigen (CEA) as tumor marker in lung cancer | Q37966302 |
| | Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer | Q37998755 |
| | Genes and pathology of non-small cell lung carcinoma | Q38190725 |
| | A novel compound RY10-4 induces apoptosis and inhibits invasion via inhibiting STAT3 through ERK-, p38-dependent pathways in human lung adenocarcinoma A549 cells | Q39050063 |
| | Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. | Q39243998 |
| | Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer | Q39278064 |
| | Overview of genetic and molecular events in the pathogenesis of lung cancer | Q40850604 |
| | The pTNM Classification of Carcinomas of the Lung, and its Prognostic Significance* | Q41447160 |
| | Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer | Q44382368 |
| | Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance | Q44526695 |
| | Multidisciplinary management of lung cancer | Q44887182 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung neoplasm | Q15124212 |
| | non-small-cell lung carcinoma | Q3658562 |
| | tumor biomarker | Q66205818 |
| | Metalloproteinase inhibitor 2 | Q24719803 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0124230 | |
| P577 | publication date | 2015-04-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis | |
| P478 | volume | 10 | |